Track topics on Twitter Track topics that are important to you
Neuronix has announces positive results from its pivotal, double-blind placebo-controlled, multi-center clinical study, for the assessment of safety and efficacy of the neuroAD therapy system, in the treatment of mild to moderate Alzheimer's disease.
Original Article: Neuronix seeks FDA approval for its therapy systemNEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...